or Try an Advanced Search...

    Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    B 284.49 0.36% 1.03
    MDGL closed up 0.36 percent on Friday, July 26, 2024, on 38 percent of normal volume.
    Earnings due: Aug 6
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical MDGL trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Three Weeks Tight Range Contraction 0.00%
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    20 DMA Support Bullish 0.36%
    Bollinger Band Squeeze Range Contraction 0.36%
    Crossed Above 20 DMA Bullish 0.87%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.87%
    Older End-of-Day Signals for MDGL ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 11 hours ago
    10 DMA Support about 11 hours ago
    Outside Day about 11 hours ago
    Fell Below Previous Day's Low about 11 hours ago
    Down 2 % about 12 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MDGL Chart by TradingView
    Basic chart:

    Profile

    Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases

    Is MDGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 24 Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024
    Jul 3 Unveiling Three US Growth Companies With High Insider Ownership
    Jun 30 Is Madrigal Pharmaceuticals a Millionaire Maker?
    Jun 16 Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
    Jun 15 Where Will Madrigal Pharmaceuticals Be in 3 Years?
    Jun 12 Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Jun 12 Madrigal Pharmaceuticals: The GLP-1 Threat May Be Overcooked
    Jun 11 Wolfe starts Madrigal at outperform, cites Rezdiffra launch
    Jun 10 Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
    Jun 9 Madrigal May Not Be Able To Shrug GLP-1 Drugs For Long
    See more MDGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 299.98
    52 Week Low 119.7604
    Average Volume 436,647
    200-Day Moving Average 224.51
    50-Day Moving Average 263.66
    20-Day Moving Average 281.48
    10-Day Moving Average 280.60
    Average True Range 12.81
    RSI (14) 55.56
    ADX 14.28
    +DI 20.37
    -DI 15.84
    Chandelier Exit (Long, 3 ATRs) 259.57
    Chandelier Exit (Short, 3 ATRs) 303.79
    Upper Bollinger Bands 294.46
    Lower Bollinger Band 268.51
    Percent B (%b) 0.62
    BandWidth 9.22
    MACD Line 4.66
    MACD Signal Line 5.88
    MACD Histogram -1.2194
    Fundamentals Value
    Market Cap 5.62 Billion
    Num Shares 19.7 Million
    EPS -19.24
    Price-to-Earnings (P/E) Ratio -14.79
    Price-to-Sales 0.00
    Price-to-Book 168.57
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 304.41
    Resistance 3 (R3) 304.01 296.96 301.09
    Resistance 2 (R2) 296.96 291.89 297.16 299.98
    Resistance 1 (R1) 290.72 288.75 287.20 291.13 298.88
    Pivot Point 283.68 283.68 281.92 283.88 283.68
    Support 1 (S1) 277.44 278.60 273.92 277.85 270.10
    Support 2 (S2) 270.40 275.47 270.60 269.00
    Support 3 (S3) 264.16 270.40 267.89
    Support 4 (S4) 264.57